Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-05

Clinical Trial Update: A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of the OZURDEX dexamethasone intravitreal implant in patients with diabetic macular edema completed, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Retinal Consultants of Arizona | Conditions: Macular Edema, Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2017-04-05